Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
500.65Price to Sales
VS
Market
Sector
Industry
History
$ 2.65Close
$ 1.55 - $ 2.72 52-Week Range
Ticker Information
Ticker
ENTXCompany Name
ENTERA BIO LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENTERA BIO LTD - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ENTX - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 83.11M | 500.65 | $ 166K |
| 3/31/2025 | $ 97.72M | 438.22 | $ 223K |
| 12/31/2024 | $ 79.49M | 439.15 | $ 181K |
| 9/30/2024 | $ 63.35M | 639.91 | $ 99K |
| 6/30/2024 | $ 58.12M | 1.02K | $ 57K |
| 3/31/2024 | $ 88.03M | 0 | $ 0 |
| 12/31/2023 | $ 49.32M | 0 | $ 0 |
| 9/30/2023 | $ 20.75M | 1.48K | $ 14K |
| 6/30/2023 | $ 21.32M | 969.2 | $ 22K |
| 3/31/2023 | $ 23.63M | 357.99 | $ 66K |
Key Performance Insights, Last 5 Years
- ENTERA BIO LTD's latest trailing twelve months (TTM) P/S stands at 38.22.
- Over the past 5 years, ENTERA BIO LTD's average P/S has been 414.84.
- The median P/S for ENTERA BIO LTD during this period was 289.93
- ENTERA BIO LTD reached its highest P/S over the past 5 years at 1.48K.
- The lowest P/S recorded by ENTERA BIO LTD in the same timeframe 38.22
ENTERA BIO LTD's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ENTERA BIO LTD is calculated as follows: Market Cap [ $ 19.65M ] / Revenues [ $ 514K ]
(=) P/S [ 38.22 ] ENTX - Price to Sales, Last 5 years
38.22
Minimum
Sep 30, 2020
1.48K
Maximum
Sep 30, 2023
414.84
Average
289.93
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |